Celcuity Inc.
CELCNasdaqCIK 1603454HealthcareFiscal year ends Dec 31
Reports and events: 156 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-08-1416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-032197 |
| 2024-05-3117:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-022227 |
| 2024-05-3007:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-021864 |
| 2024-05-1517:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-019974 |
| 2024-05-1516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-019852 |
| 2024-05-1317:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-018943 |
| 2024-03-2917:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-24-012030 |
| 2024-03-2817:15 ET | DEF 14A | Proxy statementPeriod 2024-03-28 | 0001493152-24-011792 |
| 2024-03-2717:15 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-011549 |
| 2024-03-2716:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-011514 |
| 2023-12-0517:25 ET | 8-K | 8.01 Other events | 0001493152-23-043751 |
| 2023-11-1314:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-040434 |
| 2023-11-1307:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-040317 |
| 2023-10-2317:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-038005 |
| 2023-08-2418:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-23-030000 |
| 2023-08-2217:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-029858 |
| 2023-08-1117:00 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-027869 |
| 2023-08-1016:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-027544 |
| 2023-05-1517:00 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-017491 |
| 2023-05-1516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-017289 |
| 2023-05-1216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-23-016627 |
| 2023-04-0717:00 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001493152-23-011587 |
| 2023-03-3108:00 ET | DEF 14A | Proxy statementPeriod 2023-03-31 | 0001493152-23-009927 |
| 2023-03-2317:16 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-008724 |
| 2023-03-2316:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-008693 |
| 2023-03-1517:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-007785 |
| 2023-03-1319:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001493152-23-007302 |
| 2022-12-2317:00 ET | 8-K | 2.03 New direct financial obligation | 0001493152-22-036496 |
| 2022-11-1017:20 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001493152-22-031433 |
| 2022-11-1016:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-031332 |
| 2022-11-0917:15 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001493152-22-031158 |
| 2022-09-1417:15 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-22-025891 |
| 2022-09-1216:04 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-22-000554 |
| 2022-09-0116:10 ET | 8-K | 5.07 Shareholder vote results | 0001493152-22-024841 |
| 2022-08-1217:01 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001493152-22-022400 |
| 2022-08-1116:00 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-22-022062 |
| 2022-07-2917:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-22-020778 |
| 2022-07-1917:00 ET | DEF 14A | Proxy statementPeriod 2022-07-19 | 0001493152-22-019851 |
| 2022-05-2417:10 ET | SC 13D | Ownership report, active investor | 0001072613-22-000433 |
| 2022-05-1917:25 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-22-014511 |
| 2022-05-1817:18 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-014348 |
| 2022-05-1617:15 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001493152-22-013953 |
| 2022-05-1617:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-013952 |
| 2022-05-1617:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001493152-22-013940 |
| 2022-04-1111:00 ET | DEF 14A | Proxy statementPeriod 2022-04-11 | 0001493152-22-009552 |
| 2022-03-2317:15 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001493152-22-007560 |
| 2022-03-2316:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-007535 |
| 2022-02-0417:11 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-22-003285 |
| 2021-11-0913:00 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001493152-21-027618 |
| 2021-11-0817:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-21-011792 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 20:37 ET. Listed shows no prices and gives no investment advice.